Exacerbations in cystic fibrosis: 4. Non-cystic fibrosis bronchiectasis

被引:71
|
作者
Chang, A. B. [1 ,2 ]
Bilton, D. [3 ]
机构
[1] Charles Darwin Univ, Menzies Sch Hlth Res, Child Hlth Div, Brisbane, Qld, Australia
[2] Charles Darwin Univ, Royal Childrens Hosp, Dept Resp Med, Brisbane, Qld, Australia
[3] Papworth Hosp, Lung Def Unit, NHS Trust, Cambridge CB3 8RE, England
关键词
D O I
10.1136/thx.2006.060913
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Bronchiectasis unrelated to cystic fibrosis (CF) is increasingly recognised as an important and major primary respiratory disease in developing countries. In affluent countries, bronchiectasis is also increasingly recognised in subsections of communities (such as indigenous peoples) as well as a co-existent disease/co-morbidity and disease modifier in respiratory diseases such as chronic obstructive pulmonary disease. The epidemiology, pathogenesis, prevention and management of exacerbations of non-CF bronchiectasis are reviewed. There are few data on all aspects of exacerbations in bronchiectasis. Some of the management issues are common to non-CF and CF bronchiectasis, but it would be unwise to extrapolate from CF studies to non-CF bronchiectasis. In some situations this may be harmful.
引用
收藏
页码:269 / 276
页数:8
相关论文
共 50 条
  • [31] Comparative microbiome analysis in cystic fibrosis and non-cystic fibrosis bronchiectasis.
    Motta, Heryk
    Reuwsaat, Julia Catarina Vieira
    Lopes, Fernanda Cortez
    Viezzer, Graciele
    Volpato, Fabiana Caroline Zempulski
    Barth, Afonso Luis
    de Tarso Roth Dalcin, Paulo
    Staats, Charley Christian
    Vainstein, Marilene Henning
    Kmetzsch, Livia
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [32] Comparison Of The Microbiota Of The Airway In Children With Cystic Fibrosis And Non-Cystic Fibrosis Bronchiectasis
    Green, R. J.
    Vosloo, S.
    Masekela, R.
    De Beer, S.
    Venter, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [33] Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis
    Bar-Yoseph, Ronen
    Ilivitzki, Anat
    Gur, Michal
    Mainzer, Gur
    Hakim, Fahed
    Livnat, Galit
    Schnapp, Zeev
    Shalloufeh, George George
    Zucker-Toledano, Merav
    Subar, Yael
    Bentur, Lea
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [34] Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways
    Sanjay H. Chotirmall
    Maria Teresa Martin-Gomez
    Mycopathologia, 2018, 183 : 45 - 59
  • [35] Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
    Bergin, David A.
    Hurley, Killian
    Mehta, Adwait
    Cox, Stephen
    Ryan, Dorothy
    O'Neill, Shane J.
    Reeves, Emer P.
    McElvaney, Noel G.
    JOURNAL OF INFLAMMATION RESEARCH, 2013, 6 : 1 - 10
  • [36] Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways
    Chotirmall, Sanjay H.
    Teresa Martin-Gomez, Maria
    MYCOPATHOLOGIA, 2018, 183 (01) : 45 - 59
  • [37] Diagnosis and management of non-cystic fibrosis bronchiectasis
    Macfarlane, Laura
    Kumar, Kartik
    Scoones, Thomas
    Jones, Andrew
    Loebinger, Michael R.
    Lord, Robert
    CLINICAL MEDICINE, 2021, 21 (06) : E571 - E577
  • [38] Defining severity in non-cystic fibrosis bronchiectasis
    Poppelwell, Lucy
    Chalmers, James D.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2014, 8 (02) : 249 - 262
  • [39] Etiopathogenesis and management of non-cystic fibrosis bronchiectasis
    Mathioudakis, A. G.
    Mathioudakis, G. A.
    ARCHIVES OF HELLENIC MEDICINE, 2015, 32 (02): : 135 - 148
  • [40] Secondary Immunodeficiency and Non-cystic Fibrosis Bronchiectasis
    Zo, Sungmin
    Moon, Ji-Yong
    Min, Kyung Hoon
    Lee, Hyun
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2024, 87 (04) : 440 - 450